Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
For patent practitioners in this field, the lesson is that this class is shifting from a peptide paradigm to a small-molecule paradigm
The development of reaction-based AIE sensors is of our current interest and ongoing in our laboratories
However, surgery is certainly often a better long-term option for patients who do not want the expense or side-effect protocol of ongoing medications
US$ 23.98
US$ 25.66
US$ 22.89
